According to Mars Finance, biopharmaceutical company Silo Pharma (NASDAQ: SILO) announced today the launch of a cryptocurrency fund management strategy and appointed cryptocurrency infrastructure expert Corwin Yu as the first member of the cryptocurrency advisory committee. This strategy will focus on mainstream digital assets such as Bitcoin, Ethereum, and SOL.